Vasin Lee / Shutterstock.com
Proactively managing patent portfolios is an investment that pays for itself in reduced patent costs. Bruno Reynolds, who works at the consultancy arm of Isis Innovation, the technology transfer company of the University of Oxford, explains more.
According to patent information company IFI Claims, 66% of what it said were the most prolific patenting companies also feature in the Financial Times’s top 500—compelling evidence that research and development (R&D) today creates tomorrow’s successes.
But which R&D outputs will be valuable? Which patents should companies and universities invest in?
Initial patent filings are cheap, making it easy to justify a cover-all-bases approach of patenting a high proportion of R&D outputs.
You need a subscription to continue reading this content.
Start a subscription today to access the LSIPR website.
To access the full archive, digital magazines and special reports you will need to take out a paid subscription.
News stories up to a week old and feature articles on the day of publication are accessible with a BASIC FREE ACCOUNT.
Register here for free content, or subscribe for access to archive.
If you have already subscribed please login.
If you have any technical issues please email tech support.
For access to the complete website, archive, and to receive print publications, choose '12 MONTH SUBSCRIPTION'. For a free, two-week trial with full access, select ‘TWO WEEK FREE TRIAL’; and for basic access to the latest news on the website and weekly email news alerts choose the 'BASIC FREE ACCOUNT' registration.
Bruno Reynolds; Oxford Gene Technology; Isis Enterprise; R&D; IP portfolio; University of Oxford
